LIF R

LIF R 분자 정보

영어 이름Leukemia inhibitory factor receptor시판 약물 수0
임상 약물 수2표적 별명LIF receptor,LIF-R,CD118
최고 연구 개발 단계Phase 2 Clinical
영어 이름Leukemia inhibitory factor receptor
표적 별명LIF receptor,LIF-R,CD118
시판 약물 수0
임상 약물 수2
최고 연구 개발 단계Phase 2 Clinical

LIF R 제품 목록

  • 속성

    Protein (1)

  • 제품 라이브러리

    온라인 (1)

  • Human (1)

  • 태그

    Fc Tag (1)

  • 마커

    Unconjugated (1)

제품 번호발현 시스템제품 설명단백질 구조순도특성
Human
HEK293
Human LIF R / CD118 Protein, Fc Tag
총 수량1
  • 1

LIF R분자 배경

Leukemia inhibitory factor receptor is also known as LIFR; CD118; FLJ98106; FLJ99923; LIF-R; SJS2; STWS; SWS, is the receptor for leukemia inhibitory factor (LIF). The leukemia inhibitory factor is a polyfunctional cytokine that affects the differentiation, survival, and proliferation of a wide variety of cells in the adult and the embryo. LIF action appears to be mediated through a high-affinity receptor complex composed of a low-affinity LIF binding chain (LIF receptor) and a high-affinity converter subunit, gp130. Both LIFR and gp130 are members of a family of cytokine receptors that includes components of the receptors for the majority of hematopoietic cytokines and for cytokines that affect other systems, including the ciliary neurotrophic factor, growth hormone and prolactin Defects in LIFR are the cause of Stueve-Wiedemann syndrome (SWS), a severe autosomal recessive condition and belongs to the group of the bent-bone dysplasias.

LIF R분자 별명

LIFR,CD118,FLJ98106,FLJ99923,SJS2,STWS,SWS

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
Cardiotrophin-1 (Digna Biotech/Biotecnol)CT-1Phase 2 ClinicalBiotecnol Sa, Digna Biotech Sl, Genentech IncAcute Kidney Injury; Ischemia; Liver Failure; Myocardial Reperfusion Injury
상세
MSC-1 (Northern Biologics)Phase 1 ClinicalMosaic BiosciencesCarcinoma, Non-Small-Cell Lung; Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Solid tumours
상세
  • 분자 정보
  • 제품 목록
  • 임상 약물 정보
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호